Min-101 question

If anybody has good articles on it go ahead and post it.

Is it a standalone ap or is it something to be taken in conjunction with a regular ap to combat negatives? Is it viable that every schizophrenic could take it to combat negatives along with an ap that works for them?

I’m thinking about buying some stock in it if I can come up with the money.

1 Like
4 Likes

This was recently posted.

https://globenewswire.com/news-release/2018/08/22/1555107/0/en/Minerva-Neurosciences-Announces-Findings-Showing-Effect-of-Roluperidone-on-Brain-Derived-Neurotrophic-Factor-BDNF.html

MIN-101 is being tested as a stand alone for people with predominantly negative symptoms.

The company apparently thought it would be easier to get it approved for negative symptoms as a stand alone, or so I have read. I don’t know, people combine APs and APs and ADs, so I’m sure it will be tried.

1 Like

This topic was automatically closed 14 days after the last reply. New replies are no longer allowed.